These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


235 related items for PubMed ID: 19356909

  • 1. Increased use of antibiotics in patients treated with clozapine.
    Nielsen J, Foldager L, Meyer JM.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):483-6. PubMed ID: 19356909
    [Abstract] [Full Text] [Related]

  • 2. Geographical and temporal variations in clozapine prescription for schizophrenia.
    Nielsen J, Røge R, Schjerning O, Sørensen HJ, Taylor D.
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):818-24. PubMed ID: 22503785
    [Abstract] [Full Text] [Related]

  • 3. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA.
    N Engl J Med; 1993 Jul 15; 329(3):162-7. PubMed ID: 8515788
    [Abstract] [Full Text] [Related]

  • 4. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May 15; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 5. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
    Nielsen J, Nielsen RE, Correll CU.
    J Clin Psychopharmacol; 2012 Oct 15; 32(5):678-83. PubMed ID: 22926603
    [Abstract] [Full Text] [Related]

  • 6. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y, Scholte WF.
    Tijdschr Psychiatr; 2006 Oct 15; 48(4):295-302. PubMed ID: 16955993
    [Abstract] [Full Text] [Related]

  • 7. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM, Rittmannsberger H.
    Psychiatr Prax; 2006 May 15; 33(4):194-6. PubMed ID: 16680627
    [No Abstract] [Full Text] [Related]

  • 8. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G.
    Haematologica; 2000 Mar 15; 85(3):233-7. PubMed ID: 10702809
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S.
    Postgrad Med J; 2005 Sep 15; 81(959):545-6. PubMed ID: 16143678
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
    Gerson SL.
    N Engl J Med; 2006 Apr 27; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
    [No Abstract] [Full Text] [Related]

  • 17. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
    Bergman M, Bignone I, Bisio A, Bologna V, Sabatini A.
    Vertex; 2011 Apr 27; 22(96):94-7. PubMed ID: 21977603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.
    J Clin Psychiatry; 2011 Dec 27; 72(12):1659. PubMed ID: 22244024
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.